Erectile dysfunction therapeutic agent
AssigneeMeis Technology Inc.
InventorsSeiji Matsumoto, Tokunori Yamamoto, Yuji Hotta, Kazunori Kimura
Life of this patent
Estimating the term…
Abstract
An object of the present invention is to provide a novel therapeutic strategy for erectile dysfunction. Disclosed is a therapeutic agent for erectile dysfunction, including a filtrate obtained by filtering a disrupted solution of adipose tissue-derived stem cells or bone marrow-derived stem cells.
Claims10
A therapeutic agent for erectile dysfunction, comprising a filtrate obtained by filtering a disrupted solution of adipose tissue-derived stem cells or bone marrow-derived stem cells.
A method for producing a therapeutic agent for erectile dysfunction, comprising following steps (1) to (3):
- (1) disrupting adipose tissue-derived stem cells or bone marrow-derived stem cells;
- (2) obtaining a filtrate by filtering a disrupted solution obtained in step (1), or a supernatant obtained by centrifuging the disrupted solution;
- and
- (3) formulating the filtrate obtained in step (2).
Dependencies are inferred from the claim text.